On December 17, a total of 3,746 A-shares were purchased with financing capital, and 342 shares were purchased with a purchase amount exceeding 100 million yuan. Among them, Xinyisheng, Shenghong Technology, and Zhongji Xuchuang Finance ranked in the top three with purchases of 3.334 billion yuan, 2,993 billion yuan, and 2,753 billion yuan respectively. Judging from the share of financing purchases in the total transaction amount for the day, 9 individual stocks accounted for more than 30% of the financing purchase amount. Among them, Anxu Biotech, Shengnuo Biotech, and Sichuan Shuangma Finance ranked in the top three for the share of turnover, with 48.29%, 41.51%, and 40.4% respectively. Judging from the net purchase amount of financing, 21 individual stocks received a net purchase of over 100 million yuan. Among them, C Muxi-U, Tianfu Communications, and Shenghong Technology Finance ranked in the top three with net purchases of 805 million yuan, 751 million yuan, and 305 million yuan respectively.

On December 17, a total of 3,746 A-shares were purchased with financing capital, and 342 shares were purchased with a purchase amount exceeding 100 million yuan. Among them, Xinyisheng, Shenghong Technology, and Zhongji Xuchuang Finance ranked in the top three with purchases of 3.334 billion yuan, 2,993 billion yuan, and 2,753 billion yuan respectively. Judging from the share of financing purchases in the total transaction amount for the day, 9 individual stocks accounted for more than 30% of the financing purchase amount. Among them, Anxu Biotech, Shengnuo Biotech, and Sichuan Shuangma Finance ranked in the top three for the share of turnover, with 48.29%, 41.51%, and 40.4% respectively. Judging from the net purchase amount of financing, 21 individual stocks received a net purchase of over 100 million yuan. Among them, C Muxi-U, Tianfu Communications, and Shenghong Technology Finance ranked in the top three with net purchases of 805 million yuan, 751 million yuan, and 305 million yuan respectively.